| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/15/2011 | CA2301826C Chimeric binding peptide library screening method |
| 02/15/2011 | CA2295332C Aib1, a novel steroid receptor co-activator |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2286397C Humanized antibodies and methods for forming humanized antibodies |
| 02/15/2011 | CA2200691C Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/15/2011 | CA2074370C Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 02/10/2011 | WO2011017514A1 Methods for purifying a target protein from one or more impurities in a sample |
| 02/10/2011 | WO2011017303A1 Method for in vivo expansion of t regulatory cells |
| 02/10/2011 | WO2011017294A1 Human anti-rankl antibodies |
| 02/10/2011 | WO2011016568A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016567A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016239A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016238A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011015926A1 A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein |
| 02/10/2011 | WO2011015922A1 A highly efficient process of purification and production of recombinant tnk-tpa (tenecteplase) |
| 02/10/2011 | WO2011015921A1 A highly efficient process of purification and production of recombinant cetuximab |
| 02/10/2011 | WO2011015919A1 A highly efficient process of purification and production of recombinant infliximab |
| 02/10/2011 | WO2011015602A2 Lung cancer biomarkers |
| 02/10/2011 | WO2011015590A1 Immunogenic composition comprising variants of staphylococcal clumping factor a |
| 02/10/2011 | WO2011015521A1 Beta cell marker antibody |
| 02/10/2011 | WO2011015381A1 Method for prognosis of pulmonary arterial hypertension by detecting anti-par1-antibodies |
| 02/10/2011 | WO2011015380A1 Method for prognosis of pulmonary arterial hypertension by detecting anti-par2-antibodies |
| 02/10/2011 | WO2011015121A1 Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |
| 02/10/2011 | WO2011014947A1 Porphyromonas gingivalis polypeptides |
| 02/10/2011 | WO2010028798A8 Multivalent antibodies |
| 02/10/2011 | WO2009158618A8 Avian reoviridae |
| 02/10/2011 | US20110035841 Lipid Metabolism Proteins, Combinations of Lipid Metabolism Proteins and Uses Thereof |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034677 Recurrent gene fusions in prostate cancer |
| 02/10/2011 | US20110034676 Anti-sialic acid antibody molecules |
| 02/10/2011 | US20110034675 Ilt3 Binding Molecules And Uses Therefor |
| 02/10/2011 | US20110034674 Virus filtration methods |
| 02/10/2011 | US20110034673 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 02/10/2011 | US20110034383 Cxcl12 gamma a chemokine and uses thereof |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110034368 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 02/10/2011 | US20110034345 Methods for diagnosis of maculopathies |
| 02/10/2011 | US20110034344 Response gene to complement 32 (rgc-32) in disease |
| 02/10/2011 | US20110033929 Uses of antibodies to mammalian dc langerhans cell antigen |
| 02/10/2011 | US20110033895 Method For Producing Human Antibodies With Properties Of Agonist, Antagonist, or Inverse Agonist |
| 02/10/2011 | US20110033892 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 02/10/2011 | US20110033874 Biomarkers |
| 02/10/2011 | US20110033873 Proteinic marker for early diagnosis of liver cancer |
| 02/10/2011 | US20110033870 Hybridoma producing antibodies to lawsonia intracellularis |
| 02/10/2011 | US20110033868 Use of a nitrated protein or peptide sequence for the implementation of a method of diagnosis |
| 02/10/2011 | US20110033852 Present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 02/10/2011 | US20110033838 Surface antigen protein mutant of hepatitis b virus surface antigen |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033492 Vaccines for brucellosis |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033482 Her3 as a determinant for the prognosis of melanoma |
| 02/10/2011 | US20110033479 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases |
| 02/10/2011 | US20110033478 Canine thymic stromal lymphopoietin protein and uses thereof |
| 02/10/2011 | US20110033477 Method for diagnosing and treating chronic psychiatric illnesses and markers and targets for such methods |
| 02/10/2011 | US20110033476 Compositions and methods for the therapy and diagnosis of influenza |
| 02/10/2011 | US20110033473 Anti influenza antibodies and uses thereof |
| 02/10/2011 | US20110033472 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033467 Compositions and methods comprising a ligand of chemerinr |
| 02/10/2011 | US20110033465 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 02/10/2011 | US20110033462 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use |
| 02/10/2011 | US20110033458 Combinations comprising epothilones and pharmaceutical uses thereof |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033454 Methods For Treating Diseases Using Antibodies to Aminophospolipids |
| 02/10/2011 | US20110033452 Anti-Glypican 3 Antibody Having Modified Sugar Chain |
| 02/10/2011 | US20110033450 Antibody Against Anthrax Toxins |
| 02/10/2011 | US20110033449 Human immune therapies using a CD27 agonist alone or in combination with other immune modulators |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033445 Carbohydrate-containing pan cancer marker |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | DE112009000507T5 Neue Antigen-bindende Dimerkomplexe, Verfahren zu ihrer Herstellung und ihre Verwendung New antigen binding Dimerkomplexe, processes for their preparation and their use |
| 02/10/2011 | CA2806840A1 Method for in vivo expansion of t regulatory cells |
| 02/10/2011 | CA2769748A1 Immunogenic composition comprising variants of staphylococcal clumping factor a |
| 02/10/2011 | CA2769464A1 Humanized anti-amyloid-.beta. oligomer antibody |
| 02/10/2011 | CA2769406A1 Lung cancer biomarkers |
| 02/10/2011 | CA2769231A1 Porphyromonas gingivalis polypeptides |
| 02/10/2011 | CA2769001A1 Novel proteins |
| 02/10/2011 | CA2768745A1 Beta cell marker antibody |
| 02/09/2011 | EP2281882A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus |
| 02/09/2011 | EP2281845A1 Stable polyvalent antibody |
| 02/09/2011 | EP2281844A1 MUC 1 antibodies |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281841A2 Biomarkers for pre-selection of patients for anti-IGF1R therapy |
| 02/09/2011 | EP2281840A2 Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 02/09/2011 | EP2281839A2 Methods for reducing biofilm formation in infectious bacteria |
| 02/09/2011 | EP2281838A1 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 02/09/2011 | EP2281837A2 Antigen binding domains from fish |
| 02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281576A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 02/09/2011 | EP2281575A1 Antibodies for treating cancer |
| 02/09/2011 | EP2281005A2 Single domain antibodies capable of modulating bace activity |
| 02/09/2011 | EP2281004A1 Prostate specific membrane antigen antibodies and antigen binding fragments |